Annual report [Section 13 and 15(d), not S-K Item 405]

DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Details Narrative)

v3.25.1
DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
May 17, 2024
Nov. 17, 2023
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]          
Proceeds from sale of equity       $ 184,830  
Stock issuance costs         $ 629,900
Gain on exercise of series B warrants       $ 165,355  
Series A Warrant [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Closing price       $ 4.37  
Fair value of warrant       $ 13.11  
Warrants outstanding       8,517  
Warrant liability       $ 111,658  
Series B Warrant [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Closing price $ 231.20        
Fair value of warrant $ 187.27        
Gain recognized on warrants       2,174,673  
Change in fair value of warrants $ 3,405,662        
Series A And B Warrants [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Stock issuance costs     $ 1,451,249    
Series A Warrants [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Proceeds from sale of equity   $ 10,990,530      
Series B Warrants [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Proceeds from sale of equity   $ 3,345,961      
May 2023 Warrants [Member]          
Derivative Instruments, Gain (Loss) [Line Items]          
Gain on fair value of conversion features       $ 5,107,794